Details of the Drug | DrugMAP

General Information of Drug (ID: DMPLDAK)

Drug Name

Levotofisopam

Synonyms

S-tofisopam

Indication

Disease Entry	ICD 11	Status	REF
Anxiety disorder	6B00-6B0Z	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C22H26N2O4
Canonical SMILES: CCC1C(=NN=C(C2=CC(=C(C=C12)OC)OC)C3=CC(=C(C=C3)OC)OC)C
InChI: 1S/C22H26N2O4/c1-7-15-13(2)23-24-22(14-8-9-18(25-3)19(10-14)26-4)17-12-21(28-6)20(27-5)11-16(15)17/h8-12,15H,7H2,1-6H3/t15-/m1/s1
InChIKey: RUJBDQSFYCKFAA-OAHLLOKOSA-N

Cross-matching ID

PubChem CID: 7048810
CAS Number: 82059-51-6
TTD ID: D03IBI

References

1	ClinicalTrials.gov (NCT01519687) Study of Levotofisopam 50 mg Three Times a Day (TID) Administered for 7 Days on Hyperuricemia and Gout. U.S. National Institutes of Health.